Breaking News Instant updates and real-time market news.

CAKE

Cheesecake Factory

$47.37 /

-2.68 (-5.35%)

17:01
02/17/21
02/17
17:01
02/17/21
17:01

Cheesecake Factory maintains long-term unit growth target of 3%

In post-COVID environment, the company backs its long-term units growth forecast of 3% for Cheesecake Factory and 20% at North Italia. Cheesecake Factory sees its long-term FRC unit growth of 15%-20% vs. 15% prior. Reference Link

  • 17

    Feb

CAKE Cheesecake Factory
$47.37 /

-2.68 (-5.35%)

01/28/21 Deutsche Bank
Cheesecake Factory downgraded to Hold on valuation at Deutsche Bank
01/27/21 Deutsche Bank
Cheesecake Factory downgraded to Hold from Buy at Deutsche Bank
01/25/21 JPMorgan
Texas Roadhouse cut to Underweight on Cheesecake valuation gap at JPMorgan
01/25/21 JPMorgan
Cheesecake Factory upgraded to Neutral with $44 price target at JPMorgan

TODAY'S FREE FLY STORIES

Earnings
NIO sees Q1 revenue $1.13B-$1.16B, consensus $718.49M » 17:04
03/01/21
03/01
17:04
03/01/21
17:04
NIO

NIO

$49.79 /

+3.08 (+6.59%)

In Q1, deliveries of the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
01/22/21
Fly Intel: Top five analyst initiations
NIO NIO
$49.79 /

+3.08 (+6.59%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

Syndicate
Morgan Stanley files to sell 2.32M shares of common stock for holders  17:04
03/01/21
03/01
17:04
03/01/21
17:04
MS

Morgan Stanley

$79.17 /

+2.295 (+2.99%)

 
ShowHide Related Items >><<
MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

01/25/21 Credit Suisse
Morgan Stanley price target raised to $84 from $74 at Credit Suisse
01/21/21 DA Davidson
Morgan Stanley price target raised to $90 from $80 at DA Davidson
01/21/21 Barclays
Morgan Stanley price target raised to $95 from $88 at Barclays
01/21/21 RBC Capital
Morgan Stanley price target raised to $78 from $55 at RBC Capital
MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

MS Morgan Stanley
$79.17 /

+2.295 (+2.99%)

Hot Stocks
Macy's eliminates COO role, appoints Laura Miller as Chief Information Officer » 17:03
03/01/21
03/01
17:03
03/01/21
17:03
M

Macy's

$15.32 /

+0.12 (+0.79%)

Macy's announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
M Macy's
$15.32 /

+0.12 (+0.79%)

M Macy's
$15.32 /

+0.12 (+0.79%)

02/24/21 Credit Suisse
Macy's price target raised to $13 from $7 at Credit Suisse
02/24/21 Deutsche Bank
Macy's price target raised to $16 from $15 at Deutsche Bank
02/18/21 Morgan Stanley
Macy's price target raised to $11 from $6 at Morgan Stanley
01/21/21 Deutsche Bank
Macy's price target raised to $15 from $9 at Deutsche Bank
M Macy's
$15.32 /

+0.12 (+0.79%)

M Macy's
$15.32 /

+0.12 (+0.79%)

M Macy's
$15.32 /

+0.12 (+0.79%)

M Macy's
$15.32 /

+0.12 (+0.79%)

Hot Stocks
TriCo Bancshares announces buyback for up to 2M shares of common stock » 17:02
03/01/21
03/01
17:02
03/01/21
17:02
TCBK

TriCo Bancshares

$44.39 /

+1.06 (+2.45%)

TriCo Bancshares approved…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

10/28/20 Stephens
TriCo Bancshares resumed with an Equal Weight at Stephens
TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

Earnings
NIO reports Q4 adjusted EPS (14c), consensus (7c) » 17:02
03/01/21
03/01
17:02
03/01/21
17:02
NIO

NIO

$49.79 /

+3.08 (+6.59%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
01/22/21
Fly Intel: Top five analyst initiations
NIO NIO
$49.79 /

+3.08 (+6.59%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

Hot Stocks
TriCo Bancshares raises quarterly dividend to 25c from 22c per share » 17:01
03/01/21
03/01
17:01
03/01/21
17:01
TCBK

TriCo Bancshares

$44.39 /

+1.06 (+2.45%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

10/28/20 Stephens
TriCo Bancshares resumed with an Equal Weight at Stephens
TCBK TriCo Bancshares
$44.39 /

+1.06 (+2.45%)

Syndicate
NetApp files automatic mixed securities shelf  16:59
03/01/21
03/01
16:59
03/01/21
16:59
NTAP

NetApp

$65.22 /

+2.63 (+4.20%)

 
ShowHide Related Items >><<
NTAP NetApp
$65.22 /

+2.63 (+4.20%)

NTAP NetApp
$65.22 /

+2.63 (+4.20%)

02/26/21 Daiwa
NetApp upgraded to Outperform from Neutral at Daiwa
02/25/21 Wedbush
NetApp price target raised to $70 from $62 at Wedbush
02/25/21 Wells Fargo
NetApp price target raised to $65 from $60 at Wells Fargo
02/25/21 Credit Suisse
NetApp price target raised to $80 from $75 at Credit Suisse
NTAP NetApp
$65.22 /

+2.63 (+4.20%)

NTAP NetApp
$65.22 /

+2.63 (+4.20%)

NTAP NetApp
$65.22 /

+2.63 (+4.20%)

Hot Stocks
Genuine Parts appoints Napoleon Rutledge as chief accounting officer » 16:59
03/01/21
03/01
16:59
03/01/21
16:59
GPC

Genuine Parts

$108.29 /

+2.93 (+2.78%)

Genuine Parts announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPC Genuine Parts
$108.29 /

+2.93 (+2.78%)

GPC Genuine Parts
$108.29 /

+2.93 (+2.78%)

02/18/21 RBC Capital
Genuine Parts price target raised to $104 from $97 at RBC Capital
12/02/20
Fly Intel: Top five analyst downgrades
12/02/20 BofA
Genuine Parts double downgraded to Underperform after doubling at BofA
12/02/20 BofA
Genuine Parts downgraded to Underperform from Buy at BofA
GPC Genuine Parts
$108.29 /

+2.93 (+2.78%)

GPC Genuine Parts
$108.29 /

+2.93 (+2.78%)

Upgrade
Altair upgraded to Neutral from Sell at Goldman Sachs » 16:57
03/01/21
03/01
16:57
03/01/21
16:57
ALTR

Altair

$63.27 /

+1.72 (+2.79%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALTR Altair
$63.27 /

+1.72 (+2.79%)

ALTR Altair
$63.27 /

+1.72 (+2.79%)

02/19/21 RBC Capital
Altair price target raised to $58 from $49 at RBC Capital
12/09/20 JPMorgan
Altair upgraded to Overweight from Neutral at JPMorgan
12/08/20 Benchmark
Altair price target raised to $60 from $53 at Benchmark
11/09/20 RBC Capital
Altair price target raised to $49 from $42 at RBC Capital
ALTR Altair
$63.27 /

+1.72 (+2.79%)

ALTR Altair
$63.27 /

+1.72 (+2.79%)

Syndicate
RedHill Biopharma announces $10M bought deal offering of ADSs » 16:55
03/01/21
03/01
16:55
03/01/21
16:55
RDHL

RedHill Biopharma

$9.19 /

-0.33 (-3.47%)

RedHill Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

11/12/20 Roth Capital
RedHill Biopharma price target lowered to $12 from $16 at Roth Capital
09/11/20 BTIG
RedHill Biopharma initiated with a Buy at BTIG
08/14/20 Roth Capital
Roth Capital maintains Buy on RedHill after 'noisy' quarter
07/07/20 SMBC Nikko
RedHill Biopharma initiated with an Outperform at SMBC Nikko
RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

Syndicate
Yum China files to sell 2.1M shares of common stock  16:53
03/01/21
03/01
16:53
03/01/21
16:53
YUMC

Yum China

$59.87 /

+0.095 (+0.16%)

 
ShowHide Related Items >><<
YUMC Yum China
$59.87 /

+0.095 (+0.16%)

YUMC Yum China
$59.87 /

+0.095 (+0.16%)

01/26/21 Jefferies
Yum China price target raised to $68.70 from $63.10 at Jefferies
11/02/20 Citi
Yum China price target raised to $71.30 from $60.15 at Citi
09/10/20 Goldman Sachs
Yum China H-shares initiated with a Conviction Buy at Goldman Sachs
09/10/20 Goldman Sachs
Yum China H-shares initiated with a Conviction Buy at Goldman Sachs
YUMC Yum China
$59.87 /

+0.095 (+0.16%)

  • 04
    Sep
YUMC Yum China
$59.87 /

+0.095 (+0.16%)

YUMC Yum China
$59.87 /

+0.095 (+0.16%)

Earnings
AppFolio reports Q4 EPS (1c), consensus 7c » 16:52
03/01/21
03/01
16:52
03/01/21
16:52
APPF

AppFolio

$160.72 /

-4.985 (-3.01%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APPF AppFolio
$160.72 /

-4.985 (-3.01%)

APPF AppFolio
$160.72 /

-4.985 (-3.01%)

02/25/21 DA Davidson
AppFolio price target raised to $126 from $110 at DA Davidson
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
10/26/20 Keefe Bruyette
AppFolio initiated with a Market Perform at Keefe Bruyette
APPF AppFolio
$160.72 /

-4.985 (-3.01%)

Earnings
Adverum Biotechnologies reports Q4 EPS (39c), consensus (32c) » 16:50
03/01/21
03/01
16:50
03/01/21
16:50
ADVM

Adverum Biotechnologies

$13.29 /

+0.44 (+3.42%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

12/15/20 UBS
Adverum Biotechnologies initiated with a Neutral at UBS
11/15/20 Piper Sandler
Adverum Biotechnologies shares should grind higher over time, says Piper Sandler
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform at Raymond James
ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

  • 13
    Aug
Hot Stocks
Adverum Biotechnologies provides update on ADVM-022 clinical development path » 16:47
03/01/21
03/01
16:47
03/01/21
16:47
ADVM

Adverum Biotechnologies

$13.29 /

+0.44 (+3.42%)

Adverum Biotechnologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

12/15/20 UBS
Adverum Biotechnologies initiated with a Neutral at UBS
11/15/20 Piper Sandler
Adverum Biotechnologies shares should grind higher over time, says Piper Sandler
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform at Raymond James
ADVM Adverum Biotechnologies
$13.29 /

+0.44 (+3.42%)

  • 13
    Aug
On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:45
03/01/21
03/01
16:45
03/01/21
16:45
JNJ

Johnson & Johnson

$159.34 /

+0.92 (+0.58%)

, XOM

Exxon Mobil

$56.40 /

+2.02 (+3.71%)

, OTRK

Ontrak

$31.62 /

-27.515 (-46.53%)

, ATNX

Athenex

$5.47 /

-6.715 (-55.11%)

, DKNG

DraftKings

$68.71 /

+7.24 (+11.78%)

, MORF

Morphic

$84.57 /

+48.64 (+135.37%)

The three major averages…

ShowHide Related Items >><<
JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

10:21 Today RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
10:17 Today RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

16:38 Today JPMorgan
JPMorgan downgrades Athenex on 'huge surprise' from FDA
16:31 Today SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
16:27 Today JPMorgan
Athenex downgraded to Neutral from Overweight at JPMorgan
13:53 Today Laidlaw
Athenex price target lowered to $13 from $38 at Laidlaw
DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

09:18 Today Craig-Hallum
DraftKings price target raised to $70 from $65 at Craig-Hallum
09:09 Today Canaccord
DraftKings price target raised to $80 from $65 at Canaccord
08:39 Today Northland
DraftKings price target raised to $70 from $55 at Northland
07:05 Today Benchmark
DraftKings price target raised to $69 from $66 at Benchmark
MORF Morphic
$84.57 /

+48.64 (+135.37%)

12:48 Today Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

  • 07
    Oct
  • 10
    Sep
  • 19
    Jun
JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

Hot Stocks
Ormat Technologies calls Hindenburg Research comments 'misleading' » 16:44
03/01/21
03/01
16:44
03/01/21
16:44
ORA

Ormat Technologies

$84.64 /

-0.96 (-1.12%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORA Ormat Technologies
$84.64 /

-0.96 (-1.12%)

ORA Ormat Technologies
$84.64 /

-0.96 (-1.12%)

02/02/21 Roth Capital
Ormat Technologies price target raised to $100 from $70 at Roth Capital
01/20/21 JPMorgan
Ormat Technologies price target raised to $94 from $86 at JPMorgan
01/06/21 JPMorgan
Ormat downgraded to Neutral on valuation at JPMorgan
01/06/21 JPMorgan
Ormat Technologies downgraded to Neutral from Overweight at JPMorgan
ORA Ormat Technologies
$84.64 /

-0.96 (-1.12%)

  • 19
    Nov
ORA Ormat Technologies
$84.64 /

-0.96 (-1.12%)

Syndicate
Knoll files to sell 10.68M shares of common stock for holders  16:44
03/01/21
03/01
16:44
03/01/21
16:44
KNL

Knoll

$16.99 /

+0.59 (+3.60%)

 
ShowHide Related Items >><<
KNL Knoll
$16.99 /

+0.59 (+3.60%)

KNL Knoll
$16.99 /

+0.59 (+3.60%)

Hot Stocks
Bottomline Technologies Bottomline appoints Bruce Bowden CFO » 16:43
03/01/21
03/01
16:43
03/01/21
16:43
EPAY

Bottomline Technologies

$44.39 /

-0.44 (-0.98%)

Bottomline announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPAY Bottomline Technologies
$44.39 /

-0.44 (-0.98%)

08/07/20 RBC Capital
Bottomline Technologies price target raised to $57 from $51 at RBC Capital
05/19/20 Citi
Bottomline Technologies price target raised to $49 from $46 at Citi
05/08/20 Raymond James
Bottomline Technologies price target lowered to $51 from $66 at Raymond James
05/07/20 Craig-Hallum
Bottomline Technologies price target lowered to $53 from $68 at Craig-Hallum
EPAY Bottomline Technologies
$44.39 /

-0.44 (-0.98%)

EPAY Bottomline Technologies
$44.39 /

-0.44 (-0.98%)

Earnings
Idera Pharmaceuticals reports Q4 ex-items EPS (22c), consensus (23c) » 16:42
03/01/21
03/01
16:42
03/01/21
16:42
IDRA

Idera Pharmaceuticals

$4.90 /

+0.55 (+12.64%)

As of December 31, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IDRA Idera Pharmaceuticals
$4.90 /

+0.55 (+12.64%)

IDRA Idera Pharmaceuticals
$4.90 /

+0.55 (+12.64%)

11/02/20 JPMorgan
Idera Pharmaceuticals assumed with an Overweight at JPMorgan
09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
IDRA Idera Pharmaceuticals
$4.90 /

+0.55 (+12.64%)

Conference/Events
UBS technology analyst to hold an analyst/industry conference call » 16:42
03/01/21
03/01
16:42
03/01/21
16:42

Technology Analyst Arcuri…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
BioCryst files automatic mixed securities shelf  16:42
03/01/21
03/01
16:42
03/01/21
16:42
BCRX

BioCryst

$11.97 /

+1.175 (+10.88%)

 
ShowHide Related Items >><<
BCRX BioCryst
$11.97 /

+1.175 (+10.88%)

BCRX BioCryst
$11.97 /

+1.175 (+10.88%)

07:37 Today Cowen
Cowen starts BioCryst at Outperform with $16 price target
07:03 Today Cowen
BioCryst initiated with an Outperform at Cowen
02/26/21 Barclays
BioCryst price target raised to $13 from $9 at Barclays
02/25/21 Piper Sandler
BioCryst's U.S. launch of Orladeyo now underway, says Piper Sandler
BCRX BioCryst
$11.97 /

+1.175 (+10.88%)

  • 28
    May
BCRX BioCryst
$11.97 /

+1.175 (+10.88%)

BCRX BioCryst
$11.97 /

+1.175 (+10.88%)

BCRX BioCryst
$11.97 /

+1.175 (+10.88%)

Syndicate
Gamida Cell files to sell 6.33M ordinary shares for holders  16:41
03/01/21
03/01
16:41
03/01/21
16:41
GMDA

Gamida Cell

$9.86 /

+0.46 (+4.89%)

 
ShowHide Related Items >><<
GMDA Gamida Cell
$9.86 /

+0.46 (+4.89%)

GMDA Gamida Cell
$9.86 /

+0.46 (+4.89%)

02/10/21 H.C. Wainwright
Gamida Cell price target raised to $27 from $15 at H.C. Wainwright
02/09/21 Piper Sandler
Gamida Cell price target raised to $25 from $13 at Piper Sandler
12/14/20 Oppenheimer
Gamida Cell price target lowered to $17 from $20 at Oppenheimer
12/14/20 Piper Sandler
Gamida Cell delay does not impact peak sales, says Piper Sandler
GMDA Gamida Cell
$9.86 /

+0.46 (+4.89%)

  • 19
    May
GMDA Gamida Cell
$9.86 /

+0.46 (+4.89%)

GMDA Gamida Cell
$9.86 /

+0.46 (+4.89%)

Earnings
Aziyo Biologics sees FY21 revenue $50M-$52M, consensus $50.81M » 16:41
03/01/21
03/01
16:41
03/01/21
16:41
AZYO

Aziyo Biologics

$15.26 /

-0.205 (-1.33%)

"While COVID-19…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZYO Aziyo Biologics
$15.26 /

-0.205 (-1.33%)

AZYO Aziyo Biologics
$15.26 /

-0.205 (-1.33%)

11/19/20 Piper Sandler
Aziyo Biologics posted 'nice revenue beat' in Q3, says Piper Sandler
11/02/20 Truist
Aziyo Biologics initiated with a Buy at Truist
11/02/20 Truist
Aziyo Biologics initiated with a Buy at Truist
11/02/20 Cowen
Aziyo Biologics initiated with an Outperform at Cowen
AZYO Aziyo Biologics
$15.26 /

-0.205 (-1.33%)

  • 08
    Oct
AZYO Aziyo Biologics
$15.26 /

-0.205 (-1.33%)

Earnings
Aziyo Biologics reports Q4 EPS (57c), consensus (50c) » 16:39
03/01/21
03/01
16:39
03/01/21
16:39
AZYO

Aziyo Biologics

$15.26 /

-0.205 (-1.33%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZYO Aziyo Biologics
$15.26 /

-0.205 (-1.33%)

AZYO Aziyo Biologics
$15.26 /

-0.205 (-1.33%)

11/19/20 Piper Sandler
Aziyo Biologics posted 'nice revenue beat' in Q3, says Piper Sandler
11/02/20 Truist
Aziyo Biologics initiated with a Buy at Truist
11/02/20 Truist
Aziyo Biologics initiated with a Buy at Truist
11/02/20 Cowen
Aziyo Biologics initiated with an Outperform at Cowen
AZYO Aziyo Biologics
$15.26 /

-0.205 (-1.33%)

  • 08
    Oct
AZYO Aziyo Biologics
$15.26 /

-0.205 (-1.33%)

Syndicate
Editas Medicine files automatic mixed securities shelf  16:39
03/01/21
03/01
16:39
03/01/21
16:39
EDIT

Editas Medicine

$46.91 /

+3.08 (+7.03%)

 
ShowHide Related Items >><<
EDIT Editas Medicine
$46.91 /

+3.08 (+7.03%)

EDIT Editas Medicine
$46.91 /

+3.08 (+7.03%)

06:26 Today Barclays
Editas Medicine downgraded to Equal Weight from Overweight at Barclays
02/26/21 Truist
Editas Medicine downgraded to Hold from Buy at Truist
02/26/21 Truist
Editas Medicine downgraded to Hold from Buy at Truist
02/25/21 JPMorgan
JPMorgan cuts Editas Medicine to Underweight after 'uneventful' Q4 update
EDIT Editas Medicine
$46.91 /

+3.08 (+7.03%)

  • 21
    Jan
  • 24
    Jun
EDIT Editas Medicine
$46.91 /

+3.08 (+7.03%)

EDIT Editas Medicine
$46.91 /

+3.08 (+7.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.